Source: FirstWord Pharma

Roswell Biotechnologies: Roswell Biotechnologies Forges Early Research Collaboration for Innovative Drug Discovery with UCB

Collaboration will investigate the potential of molecular electronics sensor to digitize biology and accelerate drug discovery SAN DIEGO, June 8, 2022 /PRNewswire/ -- Roswell Biotechnologi...

Read full article »
Roswell Biotechnologies's Competitors | Roswell Biotechnologies's News | Roswell Biotechnologies's Financials
Stay up-to-date with the latest news on Roswell Biotechnologies
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Paul Mola's photo - President & CEO of Roswell Biotechnologies

President & CEO

Paul Mola

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Roswell Biotechnologies